Allograft Failure After Alemtuzumab Induction in Renal Transplantation.

被引：0
|
作者：
Willicombe, M. [1 ]
Goodall, D. [1 ]
Charif, R. [1 ]
Galliford, J. [1 ]
McLean, A. [1 ]
Taube, D. [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Kidney & Transplant Ctr, London, England
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01960
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
C1803
引用
收藏
页码：581 / 581
页数：1
相关论文
共 50 条
  • [41] Rituximab or Alemtuzumab Induction for ABO Incompatible Renal Transplantation?
    Charif, R.
    De Kort, H.
    Roufosse, C.
    Brookes, P.
    McLean, A.
    Papalois, V.
    Hakim, N.
    Taube, D.
    Galliford, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 283 - 283
  • [42] Kidney Transplantation with Alemtuzumab Induction Improves Outcomes for Female Allograft Recipients
    Demeter, Jonathan
    Zimmerman, Allison
    Mitro, Graham
    Rees, Michael
    Ortiz, Jorge
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 39 - 39
  • [43] Transplantation: Alemtuzumab induction is safe for renal transplant recipients
    Myrvang H.
    Nature Reviews Nephrology, 2011, 7 (7) : 362 - 362
  • [44] Forecasting Delayed Renal Allograft Function Prior to Transplantation.
    Goldstein, M. J.
    Ying, A.
    Dikman, S.
    Stern, J.
    Sheth, M.
    Yushkov, Y. Y.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 213 - 213
  • [45] Diffuse Alveolar Haemorrhage: A Fatal Complication After Alemtuzumab Induction Therapy in Renal Transplantation
    Tahir, W.
    Hakeem, A.
    Baker, R.
    Ahmad, N.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (01) : 151 - 154
  • [46] After Alemtuzumab Induction, Tac plus MMF Is Superior to CsA plus MMF in Pediatric Kidney Transplantation.
    Kaabak, M.
    Babenko, N.
    Zokoyev, A.
    Shapiro, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 614 - 614
  • [47] Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen
    Bolanos-Meade, J.
    Luznik, L.
    Muth, M.
    Matsui, W. H.
    Huff, C. A.
    Smith, B. D.
    Levy, M. Y.
    Kasamon, Y. L.
    Swinnen, L. J.
    Powell, J. D.
    Brodsky, R. A.
    Ambinder, R. F.
    Jones, R. J.
    Fuchs, E. J.
    BONE MARROW TRANSPLANTATION, 2009, 43 (06) : 477 - 480
  • [48] Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen
    J Bolaños-Meade
    L Luznik
    M Muth
    W H Matsui
    C A Huff
    B D Smith
    M Y Levy
    Y L Kasamon
    L J Swinnen
    J D Powell
    R A Brodsky
    R F Ambinder
    R J Jones
    E J Fuchs
    Bone Marrow Transplantation, 2009, 43 : 477 - 480
  • [49] SALVAGE TRANSPLANTATION FOR ALLOGRAFT FAILURE UTILIZING FLUDARABINE AND ALEMTUZUMAB AS THE CONDITIONING REGIMEN
    Bolanos-Meade, J.
    Luznik, L.
    Jones, R. J.
    Fucbs, E. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 110 - 110
  • [50] Outcomes of a Non-Induction Renal Sparing Approach after Liver Transplantation.
    Haywood, S.
    Rao, V.
    Abecassis, M.
    Levitsky, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 265 - 265
12345